Glycosphingolipid synthesis inhibitor AMP-DNM lowers plasma cholesterol levels by promoting fecal cholesterol excretion without inhibiting cholesterol absorption

Publication Type:

Journal Article

Source:

Clinical Lipidology, Volume 7, Number 2, pp. 241-248 (2012)

ISBN:

1758-4299

DOI Name (links to online publication)

10.2217/clp.12.14
05/06/2012